You have 9 free searches left this month | for more free features.

SARS-CoV2

Showing 1 - 25 of 5,886

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

Recruiting
  • SARS-CoV2 Infection
  • General SARS-CoV-2 Communication
  • Rural-Targeted SARS-CoV-2 Communication
  • Flint, Michigan
    Flint Journal Building
Oct 10, 2023

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

Not yet recruiting
  • SARS-CoV-2
  • +4 more
  • LumiraDx SARS-CoV-2 Ag Ultra
  • LumiraDx SARS-CoV-2 & Flu A/B
  • DeLand, Florida
    Hillcrest Medical Research
Feb 6, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

    Not yet recruiting
    • COVID-19
    • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
    • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
    • (no location specified)
    Aug 4, 2023

    SARS-CoV-2 Vaccination on Cancer Patients Infected With

    Recruiting
    • COVID-19 Infection
    • COVID-19 Vaccine
    • no intervention
    • Beijing, Beijing, China
      Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
    Mar 7, 2023

    Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

    Not yet recruiting
    • Immunogenicity
    • Safety
    • Phase II:SWIM816;SARS-Cov-2;
    • +3 more
    • (no location specified)
    Jun 18, 2023

    Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

    Not yet recruiting
    • Influenza A
    • +3 more
    • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
    • Raleigh, North Carolina
      Wake Med
    Jun 26, 2023

    Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test

    Not yet recruiting
    • SARS-CoV-2
    • +3 more
    • LumiraDx SARS-CoV-2 & Flu A/B
    • Cullman, Alabama
      Cullman Clinical Trials
    Mar 16, 2023

    SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

    Recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
    • 0.9% sodium chloride solution
    • Islamabad, Pakistan
      Sindh Infectious Diseases Hospital & Research Center Dow Univers
    Apr 16, 2023

    COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

    Recruiting
    • COVID-19
    • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
    • Guangzhou, Guangzhou, China
      The Fifth Affiliated Hospital of Guangzhou Medical University
    Jan 28, 2023

    a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul

    Completed
    • a Randomized Double-blind Study
    • +2 more
    • Sahloul, Sousse, Tunisia
      Riadh Boukef
    Jan 2, 2023

    SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586

    Recruiting
    • SARS-CoV-2
    • Prevention
    • MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
    • Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 2, 2023

    SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +2 more
    • eBAM Cov Testing
    • Marseille, France
    • +1 more
    Oct 23, 2023

    Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

    Not yet recruiting
    • Respiratory Viral Infection
    • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
    • BioFire Respiratory Panel 2.1
    • (no location specified)
    Jul 13, 2023

    SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

    Completed
    • SARS-COV2 Virus
      • Bethesda, Maryland
      • +1 more
      Dec 16, 2022

      Sars-cov-2 on Donor Oocyte Quality and Quantity,Multicenter

      Completed
      • Ovarian Reserve
      • +2 more
      • Sars Cov 2 infection
      • Sars Cov 2 vaccination
      • Bogotá, Colombia
        Novafem
      Oct 3, 2022

      Coronavirus Trial in Oxford (SARS-CoV-2 virus)

      Recruiting
      • Coronavirus
      • SARS-CoV-2 virus
      • Oxford, Oxon, United Kingdom
      • +2 more
      Jan 5, 2023

      Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)

      Active, not recruiting
      • Sars-CoV-2 Infection
      • Nasal and mouth swab
      • Negrar, Verona, Italy
        IRCCS Sacro Cuore Don Calabria hospital
      Mar 14, 2023

      Awake Prone Positioning in COVID-19 ICU Patients

      Not yet recruiting
      • SARS-CoV 2 Pneumonia
      • quality of life questionnaire
      • Tours, France
        university hospital Tours
      Oct 10, 2023

      SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)

      Active, not recruiting
      • SARS-CoV-2
      • RBMRNA-176
      • Placebo
      • Chengdu, Sichuan, China
        Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
      Jun 12, 2023